FIELD: pharmaceutical industry.
SUBSTANCE: invention relates to a pharmaceutical composition of anti-tumor action. Pharmaceutical composition of anti-tumor action, made in the form of tablets, contains as an active substance an extract of hedge hyssop and auxiliary substances—colloidal silicon dioxide, wherein the active substance used is a herb hedge hyssop dry extract, additionally added to the composition are potato starch, lactose monohydrate, magnesium stearate, wherein the tablet contains components in the following ratio, wt.%: mixture of hedge hyssop herb dry extract with lactose monohydrate containing 3% of flavonoids in terms of luteolin-7-glucoside and dry substance 50.0, potato starch—24.4, colloidal silicon dioxide—0.6, magnesium stearate—1.0, lactose monohydrate—the rest.
EFFECT: use of the invention provides a pharmaceutical composition in the form of a tablet, which corresponds to such technological parameters as abrasion, strength, disintegration, solubility, and is also stable, safe and has an extended shelf life, has a pronounced anti-tumor effect.
1 cl, 1 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR QUANTITATIVE DETERMINATION OF AMOUNT OF FLAVONOIDS IN GRATIOLE HERB | 2023 |
|
RU2829551C1 |
PHARMACEUTICAL COMPOSITION OF SEDATIVE AND ANXIOLYTIC ACTION | 2020 |
|
RU2737701C1 |
DRY TABLETTED FORMULATION OF Cetraria islandica (L.) Ach. EXTRACT | 2006 |
|
RU2321419C1 |
MEANS, POSSESSING ANTI-TUBERCULOSIS ACTION | 2014 |
|
RU2549477C1 |
AGENT BASED ON DRY MOTHERWORT EXTRACT AND METHOD FOR PRODUCTION THEREOF | 2015 |
|
RU2589507C1 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
SEDATIVE AGENT AND METHODS FOR ITS PREPARING | 2005 |
|
RU2291705C1 |
METHOD OF COMBINED LIVER CANCER PC-1 THERAPY IN EXPERIMENT | 2020 |
|
RU2734143C1 |
AGENT POSSESSING ANTI-INFLAMMATORY, ANTIPYRETIC AND ANTIMICROBIAL ACTION | 2013 |
|
RU2535155C1 |
PHARMACEUTICAL COMPOSITION WITH ANTI-THERAPEUTIC ACTIVITY AND METHOD OF ITS PRODUCTION | 2016 |
|
RU2624857C1 |
Authors
Dates
2024-12-09—Published
2023-12-28—Filed